Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, Director, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed May 8, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2024Option exercise(M)232—$07K
May 6, 2024Tax withholding(F)61$8.46$5167K
May 6, 2024Option exercise(M)211—$07K
May 6, 2024Tax withholding(F)67$8.46$5677K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2024Option exercise(M)232——2K
May 6, 2024Option exercise(M)211——2K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-018282) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML